Wavepaths

Wavepaths

Provides adaptive music both for psychedelic therapy and as psychedelic therapy, in collaboration with world class artists.

HQ location
London, United Kingdom
Launch date
Employees
Enterprise value
$18—27m
Company register number
Notes (0)
More about Wavepaths
Made with AI
Edit

Wavepaths operates at the intersection of music, technology, and psychedelic therapy, providing adaptive, AI-powered soundscapes for therapeutic settings. The company was founded in 2019 by Dr. Mendel Kaelen, a neuroscientist, and Anna Wakefield (also cited as Anna Rickman), who serves as the Chief Commercial Officer. Dr. Kaelen's background as a musician and his extensive postdoctoral research at Imperial College London directly informed the company's creation. His work revealed the critical role music plays in predicting positive outcomes in psychedelic therapy, leading to the insight that experience itself can be a form of medicine.

The core of Wavepaths' offering is a digital platform that provides therapists and care providers with tools to tailor music experiences for their clients in real-time. This technology leverages creative AI to generate music that can be adapted during a session, altering emotionality, intensity, and instrumentation to match the patient's evolving state. This approach of "person-centered music" is designed to support various therapeutic practices, including psychedelic-assisted therapy with substances like ketamine, psilocybin, and MDMA, as well as non-drug modalities such as breathwork and psychotherapy. The company collaborates with a diverse range of musicians, including Jon Hopkins and Brian Eno, to create exclusive, research-inspired compositions.

Wavepaths' business model primarily targets care providers, clinics, and research institutions through a subscription-based service. By early 2021, the platform had been adopted by hundreds of practitioners in over 30 countries. The company also offers products for individual listeners, including a "Listeners Community" with access to guided and self-guided deep listening sessions. Wavepaths has secured significant investment to scale its platform, including a $4.5 million seed round in 2021 from investors like Heron Rock and Reflex Capital. The company is actively engaged in partnerships with universities and psychedelic therapy companies to further research and validate the therapeutic potential of music.

Keywords: adaptive music, psychedelic therapy, therapeutic music, mental healthcare, AI music generation, neuroscience, Mendel Kaelen, ketamine therapy, psilocybin therapy, experiential medicine, sound therapy, digital health, psychotherapy tools, person-centered music, deep listening, music-assisted therapy, mental wellness, neuroaesthetics, generative music, clinical music

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo